Cardiovascular Disease. Congenital malformation of circulatory system, unspecified
Conditions
Interventions
Intervention 1: Intervention group: ?or every kg of body weight, 10-20 ml fresh frozen plasma (FFP) and 100-200 ml crystalloid solution (Ringer dolurion) will be used as priming solution. To maintain
Prevention
Intervention group: ?or every kg of body weight, 10-20 ml fresh frozen plasma (FFP) and 100-200 ml crystalloid solution (Ringer dolurion) will be used as priming solution. To maintain hematocrit at 20
Control group: For every kg of body weight, 10-20 ml hydroxyethyl starch with proportion of 130 to 0.4 and 100-200 ml crystalloid solution (Ringer dolurion) will be used as priming solution. To mainta
Sponsors
Vice Chancellor of research of Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion Criteria: No history of sternotomy; No coagulopathy; No hepatic diasese Exclusion Criteria: Dying patient; Giving up participation in the study; blood or blood products transfusion within the last 24 hrs
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rotem parameters. Timepoint: before anesthesia induction and after weaning from cardiopulmonary bypass machine. Method of measurement: Rotem measurement system. | — |
Secondary
| Measure | Time frame |
|---|---|
| Received boold products. Timepoint: during operation and 24hrs after surgery. Method of measurement: Milliliter. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Hamid Peyrovi
Iran University of Medical Sciences
Outcome results
None listed